CNBC's Rick Santelli has the weekly jobless claims, which are down to 358,000. Insight on whether this is a positive indicator for the econo...
Anko Beldsnijder, senior portfolio manager at MainFirst Bank, told CNBC, "as an investor you are pretty much in this drama as well, as in th...
Debating a new government mandate requiring religious organizations to provide birth control coverage in their health plans, with Igor Volsk...
Perrigo CEO, Joseph Papa discusses his company's 11% Q2 profit rise, and its outlook on growth, with Mad Money's Jim Cramer.
Rebecca Patterson, MD & Chief Markets Strategist, J.P.Morgan Asset Management says even if Greece is able to reduce its debt load, the count...
David Cordani, Cigna CEO & president, explains why Cigna and its competitors should join forces to help fight childhood obesity.
A breakdown of the company's Q4 earnings and discussing changes in the healthcare landscape, with Larry Merlo, CVS Caremark president/CEO, w...
Medical device maker, Abiomed's CEO, Michael Minogue, discusses his company's earnings beat, and whether the ultra expensive stock, selling ...
A breakdown of the drug-maker's Q4 profit after reporting a loss a year earlier, with Andrew Witty, GlaxoSmithKline CEO.
Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health are growing, with CNBC's Bertha Coombs.
Insight on the value that will be created by a transaction with Illumina, with Severin Schwan, Roche CEO, who discusses Roche's offer for Il...
Masaru Ohnishi, Chief Equity Strategist for Japan, Credit Suisse, says despite weak earnings outlooks from some of Japan's top companies inc...
Markets in Europe rally near the U.S. open, mostly on comments from the German finance minister. He also says there will be no more public a...
The job cuts in January are 23 percent higher than December, says John Challenger, Challenger, Gray & Christmas CEO who adds the retail sect...
A breakdown of the pharmaceutical giant's earnings, with John Eade, Argus Research.
Weighing in on the pharmaceuticals company's fourth quarter earnings, with John Lechleiter, Eli Lilly chairman/president/CEO, who discusses ...
CNBC's David Faber shares the conditions of the offer between Roche and Illumina.
With the market up 20 percent or more in four months, Bob Doll, BlackRock chief equity strategist, shares investment strategy and the cycli...
Insight on the GOP candidates that have a chance to be nominated, with Sen. Ron Johnson (R-WI), who also discusses Wisconsin Governor Scott ...
Posts |
SECTOR : Health Care
30 Jan 2012
Posted By:Paul Stoffels, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson CNBC Guest Blog
It’s rare for the world's leading pharmaceutical companies and other partners to work together to tackle an urgent global health issue... Read More
26 Jan 2012
Amgen and Celgene, looking to boost oncology offerings, announced separate deals for small biotech companies Thursday, the latest in what analysts expect to be a major wave of biotech mergers... Read More
9 Jan 2012
As the JPMorgan Health Care conference kicks off this week, one question remains for investors in the biotech space... Read More
9 Jan 2012
The "Patient Protection and Affordable Care Act" has been a lightning rod since its inception... Read More
6 Jan 2012
Ahead of the annual “Health Care Super Bowl” next week, the “Fast Money” pros picked a few of their favorite plays... Read More
News |
SECTOR : Health Care
Source: Reuters
Source: The Associated Press
Source: The Associated Press
Source: The Associated Press
Source: The Associated Press
Source: The Associated Press
Source: The Associated Press
Source: The Associated Press
Source: The Associated Press
Source: The Associated Press
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
